PubMed HealthSearch

PubMed · 2100599

Method validation in the bioanalytical laboratory.

Abstract

Bioanalytical methods, based on a variety of physico-chemical and biological techniques such as chromatography, immunoassay and mass spectrometry, must be validated prior to and during use to engender confidence in the results generated. The fundamental criteria for assessing the reliability and overall performance of a bioanalytical method are: the evaluation of drug and analyte stability, selectivity, limits of quantification and detection, accuracy, precision, linearity and recovery. The extent to which a method is validated is dependent on its prospective use, the number of samples to be assayed and the use to which the data are put. Specific analytical techniques may require additional validation such as antibody-binding characteristics, peak purity determination, evaluation of matrix effects or structural confirmation of the analyte. Ideally each assay should be cross-validated with a method utilizing a highly specific detector such as a mass spectrometer. Once in use, the performance of the method should be monitored using quality control standards. If a method is set up in another laboratory, the performance of that assay should be monitored with quality control standards sent from the originating laboratory.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A R Buick, M V Doig, S C Jeal, G S Land, R D McDowall. 1990. Method validation in the bioanalytical laboratory.. https://doi.org/10.1016/0731-7085(90)80093-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Mirror images: the analysis of pharmaceutical enantiomers.

Pharmaceutical enantiomers often exhibit different pharmacodynamic and pharmacokinetic properties. Stereospecific chromatographic assays are available to separate these stereoisomers. Therapeutic agents often contain chemical functional groups (e.g. amino, hydroxyl, carbonyl, and carboxylic acid). These can be reacted with enantiomerically pure reagents to give diastereoisomers suitable for analysis on achiral gas chromatographic (GC) and high performance liquid chromatographic (HPLC) columns. Alternatively, derivatized or underivatized drugs may be resolved on chiral chromatographic phases. A wide variety of GC (e.g. amino acid, cyclodextrin, and metal-complex) and HPLC (mobile phase additive, crown ether, pi-pi interaction and related phases, protein, cyclodextrin, polysaccharide, methacrylate and amide polymer, and ligand exchange) columns are commercially available. This article reviews the chromatographic separation of enantiomers.

Chemistry, Pharmaceutical

Modeling of the kinetics of drug release from a binary system.

A model of a controlled-release drug delivery system was proposed and tested by mathematical simulation. The model consisted of a cylindrical drug reservoir coated with a permeable and erodible material. The release rate is relatively constant because, while the drug concentration is diminishing, the barrier is eroding. These factors may be balanced initially, but ultimately the release rate increases or decreases markedly depending on the permeability. Two kinds of permeability-dependent behaviors were observed: (1) for high-permeability coatings, the release rate is high and constant and then decreases as the drug is exhausted; and (2) for low-permeability coatings, the release rate is low and constant and then increases as the barrier becomes thin. The proposed design combines two cylinders whose coatings have different permeabilities and exhibit complementary release behavior. Complete release occurs before total erosion of either coating. Optimization of the design and the design parameters leads to a constant release rate (within 6%) until all of the drug is released from the device.

Chemistry, Pharmaceutical